default author photo

Alexandre Bozec

Centre Antoine Lacassagne

Nice

France

SCHOLARLY PAPERS

2

DOWNLOADS

184

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Improving Surgical Scheduling Efficiency with ORCAL: A Comparative Analysis of Patient Outcomes and Operational Metrics

Number of pages: 20 Posted: 26 Mar 2025
Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne, Centre Antoine Lacassagne and Centre Antoine Lacassagne
Downloads 131 (558,171)

Abstract:

Loading...

Operating Room Scheduling, Patient Prioritization, Surgical Efficiency, Machine Learning in Healthcare, Healthcare Resource Optimization

2.

Cabozantinib, a Promising Therapeutic Strategy for Resistant Head and Neck Squamous Cell Carcinoma Patients

Number of pages: 164 Posted: 09 Aug 2021
Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Cote d'Azur - Central laboratory of Pathology, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Centre Antoine Lacassagne, Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN), Centre Antoine Lacassagne, Centre Antoine Lacassagne, Karolinska Institutet - Department of Microbiology, Tumor and Cell Biology (MTC), Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN) and Université Côte d'Azur - Institute for Research on Cancer and Aging of Nice (IRCAN)
Downloads 53 (1,031,043)

Abstract:

Loading...

AXL, c-MET, head and neck squamous cell carcinoma (HNSCC), radiotherapy, cisplatin, resistance, cabozantinib, anti-angiogenic, VEGFR inhibitor, therapy repositioning